Si-Yi Xie

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center

发表论文 10 篇 · 总被引 204 次 · h-index 5

代表论文

• Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial (2024 · The Lancet Oncology · 被引 70)
• Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial (2023 · Nature Communications · 被引 53)
• Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial (2023 · The Lancet Oncology · 被引 42)
• Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission? (2022 · Radiotherapy and Oncology · 被引 18)
• Impact of smoking on survival in nasopharyngeal carcinoma: A cohort study with 23,325 patients diagnosed from 1990 to 2016 (2021 · Radiotherapy and Oncology · 被引 18)
• Construction and validation of a biochemical signature to predict the prognosis and the benefit of induction chemotherapy in patients with nasopharyngeal carcinoma. (2022 · PubMed · 被引 2)